Table 2.
Association between the prevalence of LTBI and risk factors among PLWH at University of Gondar referral hospital, Northwest Ethiopia, 2017
| Characteristics | QuantiFERON test result | |||||
|---|---|---|---|---|---|---|
| Positive n (%) |
Negative N (%) |
P-value | COR (95% C.I.) | P-value | AOR (95% C.I.) | |
| Contact with TB case | ||||||
| Yes | 31 (73.8) | 11 (26.2) | 0.0 | 7.71 (3.2–18.3) | 0.003* | 5.2 (1.7–15.8)* |
| No | 19 (26.8) | 52 (73.2) | – | 1.0 | – | 1.0 |
| Family history with TB | ||||||
| Yes | 26 (74.3) | 9 (25.7) | 0.0 | 6.5 (2.6–16) | 0.023* | 3.8 (1.2–12)* |
| No | 24 (30.8) | 54 (69.2) | – | 1.0 | – | 3.79 (1.0) |
| INH prophylaxis | ||||||
| Yes | 4 (13.8) | 25 (86.2) | 0.0 | 0.1 (0.1–0.4) | 0.005* | 0.1 (0.03–0.6)* |
| No | 46 (54.8) | 38 (45.2) | – | 1.0 | – | 1.0 |
| ART status | ||||||
| Yes | 37 (39.8) | 56 (60.0) | – | 1.00 | – | – |
| No | 13 (65.0) | 7 (35.0) | 0.04 | 2.8 (1–7.7) | 0.138 | 2.6 (0.7–9.1) |
ART antiretroviral therapy, HIV human immunodeficiency virus, INH isonicotinylhydrazide (Isoniazid)
* P-value = < 0.05